These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [The clinical observation on serum transaminase in diseases of the liver and biliary tract]. SHIMOMURA K Kumamoto Igakkai Zasshi; 1962 Mar; 36():277-89. PubMed ID: 13911998 [No Abstract] [Full Text] [Related]
4. Serum glutamic oxalacetic transaminase in diseases of the liver and biliary tract. MADSEN S; BANG NU; IVERSEN K Br Med J; 1958 Mar; 1(5070):543-6. PubMed ID: 13510721 [No Abstract] [Full Text] [Related]
5. Serum transaminase levels in hepatobiliary diseases. DAVE JK; PARELKAR SN; GADGIL RK Indian J Med Sci; 1960 Jul; 14():601-9. PubMed ID: 13719950 [No Abstract] [Full Text] [Related]
6. [Serum transaminase in liver & biliary tract diseases]. GIBINSKI K; KOKOT F Pol Tyg Lek (Wars); 1957 Dec; 12(48):1841-6. PubMed ID: 13527242 [No Abstract] [Full Text] [Related]
7. [Glutamic oxalacetic transaminase in blood in liver & biliary disease]. MADSEN S; BANG NU; IVERSEN K Nord Med; 1957 Jul; 58(28):1008-13. PubMed ID: 13452190 [No Abstract] [Full Text] [Related]
12. The significance of serum iron determination in liver diseases. LI PK; LU HM; SHIH PC; HOU CS; KU CH; HY WY; CH'EN SH Chin Med J; 1958 May; 76(5):436-44. PubMed ID: 13561463 [No Abstract] [Full Text] [Related]
13. [Ornithine-carbamyl transferase of the serum. Its interest in hepato-biliary pathology]. MORETTI GF; STAEFFEN J; BALLAN P; DEMANGE P; GACON J Arch Mal Appar Dig Mal Nutr; 1960 Oct; 49():1379-84. PubMed ID: 13772545 [No Abstract] [Full Text] [Related]
14. [Protein content of plasma in hepato-biliary diseases]. VALLIN J; LEVY R; BADIN J; JAYLE MF Rev Prat; 1957 Apr; 7(11):1211-2. PubMed ID: 13442377 [No Abstract] [Full Text] [Related]
15. Serum aldolase in hepatobiliary disease. KATZ R; DUCCI H Am J Dig Dis; 1958 Jul; 3(7):517-21. PubMed ID: 13559191 [No Abstract] [Full Text] [Related]
16. [Transaminases. II. Significance of blood glutamic oxalacetic & glutamic pyruvic transaminases in hepatobiliary disorders]. ZERAH A; PEREZ C Tunis Med; 1958 Dec; 36(10):611 passim. PubMed ID: 13635877 [No Abstract] [Full Text] [Related]
17. Determination of transaminase activity in dogs' serum and lymph after hepatic damage due to acute biliary obstruction. BRAUN P; PAPP M; HORVATH I Nature; 1959 Jan; 183(4653):48-9. PubMed ID: 13622686 [No Abstract] [Full Text] [Related]
18. Effect of liver damage on serum glutamic oxalacetic transaminase and glutamic pyruvic transaminase. RANGAM CM; SHRIVASTAVA KK; GUPTA JC J Indian Med Assoc; 1962 Apr; 38():395-9. PubMed ID: 14490264 [No Abstract] [Full Text] [Related]
19. [On the influence of surgery on the biliary system, especially in liver diseases, on the serum level of the enzymes sorbitol dehydrogenase, glutamic-pyruvic transaminase, lactate dehydrogenase and glutamic dehydrogenase]. MASSARRAT S Acta Hepatosplenol; 1962 Apr; 9():86-103. PubMed ID: 14470895 [No Abstract] [Full Text] [Related]
20. [Serum transaminase and its significance in liver diseases]. DANILA I; COMOROSAN S; MINCU I; ILIE E Med Interna (Bucur); 1960 Jan; 12():23-32. PubMed ID: 13814001 [No Abstract] [Full Text] [Related] [Next] [New Search]